Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sara Pezzotta"'
Autor:
Cesare Perotti, Elena Antoniazzi, C. Del Fante, Paolo Emilio Bianchi, Sara Pezzotta, Gemma Caterina Maria Rossi, Luigia Scudeller
Publikováno v:
Europe PubMed Central
Current ocular GvHD (oGvHD) treatments are suboptimal. We investigated the safety and efficacy of long-term continuous treatment with autologous platelet lysate (PL) drops in patients with oGvHD Dry Eye Syndrome (DES) score 2-3 refractory to topical
Autor:
Gian Maria Pasinetti, Paolo Emilio Bianchi, Marta Raimondi, Alessio Delfino, Martina Maccarone, Luigia Scudeller, Sara Pezzotta, Elena Antoniazzi, Gemma Caterina Maria Rossi
Publikováno v:
European Journal of Ophthalmology. 22:701-708
To assess the sensitivity and specificity of Pentacam measurements in detection of occludable angles and to provide cutoff values.Observational, single-center, cross-sectional study on 64 Caucasian eyes: 28 (43.7%) primary narrow angles or primary an
Publikováno v:
European Journal of Ophthalmology. 20:517-522
PURPOSE Laser iridotomy is the standard first-line intervention in both acute and chronic forms of angle closure because it prevents the recurrence of acute attacks and virtually eliminates the risk of an acute attack in the fellow eye. Pentacam is a
Autor:
Elena Antoniazzi, C. Del Fante, Luigia Scudeller, Sara Pezzotta, Gemma Caterina Maria Rossi, Paolo Emilio Bianchi, Cesare Perotti
Publikováno v:
Bone marrow transplantation. 50(9)
Ocular GvHD affects about 40–60% of patients receiving bone marrow transplantation. Ocular complaints worsen quality of life (QoL), which, besides survival time, is a primary end point in a patient's follow-up. The aim of our study was to assess th
Publikováno v:
AIDS. 21:535-537
Autor:
Luigia Scudeller, Cesare Perotti, Elena Antoniazzi, Sara Pezzotta, Marila Cervio, C. Del Fante
Publikováno v:
Bone marrow transplantation. 47(12)
Current treatment of ocular GVHD (oGVHD), represented by systemic immunosuppressive regimens and local therapies (mainly artificial tears and corticosteroids), gives unsatisfactory results. We investigated the safety and efficacy of autologous plasma
Autor:
Raffaella Angeli, Carmine Tinelli, Chiara Bertone, Sara Pezzotta, Rosanna Guagliano, Pe Bianchi, Elisa Fazzi, M. Antonini, Giulio Ruberto, Donatella Barillà
Publikováno v:
Acta Ophthalmologica. 86
Purpose This study aimed to define the relationship between 30 herz and mixed maximal response electroretinogram, recorded under anaesthesia, and the visual outcome in subjects affected by various retinal and/or optic disk affections. Methods We pres
Autor:
Carmine Tinelli, Sara Pezzotta, Raffaella Angeli, M. Antonini, Pe Bianchi, Elisa Fazzi, Chiara Bertone, Giulio Ruberto
Publikováno v:
Acta Ophthalmologica. 86
Purpose To analyze improvement of visual acuity(VA) and visual evoked patterned potentials (pVEP) in children diagnosed by MR as cerebral visual impaired (CVI) after rehabilitation (refractive correction and occlusion terapy). Methods In 45 CVI infan
Autor:
M. Antonini, Elisa Fazzi, Sabrina Signorini, Antonella Luparia, Paolo Emilio Bianchi, Raffaella Angeli, Giulio Ruberto, Chiara Bertone, Sara Pezzotta, Carmine Tinelli
Publikováno v:
Acta Ophthalmologica Scandinavica. 85
Purpose: To analyze relationship between visual acuity (VA), visual evoked patterned potentials (VEP) and fundus state of the optic disk in children diagnosed by MR as cerebral visual impaired (CVI). Methods: Full clinical examinations, including Tel
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
The purpose of this review is to update the latest information about ocular toxoplasmosis. The infection can be congenital or acquired, but also depends about the immune condition of the patient and can affect the eye. Ocular symptoms are variable ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::af93828a392af284eb33c9d701896d51
http://www.scopus.com/inward/record.url?eid=2-s2.0-56149100621&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-56149100621&partnerID=MN8TOARS